Last checked at 16 Apr 2024 09:48
LONDON BROKER RATINGS: RBC raises Admiral; Barclays cuts Phoenix Group
(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Astrazeneca Share News (AZN)
AZN Share
Price
AZN Share
News2
AZN Share
Chat
AZN Share
Trades6,348
AZN
Live RNS
AZN Share
Charts
AZN Level 2
Console
AZN Live
Share Price
AZN Broker
Ratings
AZN Directors
Deals
AZN Financial
Diary
AZN
Fundamentals
AZN Short
Positions
AZN
Media
Astrazeneca Information
Share Price Information for Astrazeneca (AZN)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
12,310.00
Bid:
12,306.00
Ask:
12,310.00
Change:
192.00 (1.58%)
Spread:
4.00 (0.033%)
Open:
12,244.00
High:
12,384.00
Low:
12,228.00
Prev. Close:
12,118.00
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.Wednesday newspaper round-up: FCA, AstraZeneca, Greece
Wed, 03rd Jun 2015 07:29
The UK markets regulator has given his backing to asset managers fighting proposals that could see them labelled as potential threats to the financial system. Martin Wheatley, head of Britain's Financial Conduct Authority, said global regulators faced "big questions" that needed to be answered before determining whether the world's largest asset managers should be deemed "systemically important". - Financial TimesAstraZeneca chief executive Pascal Soriot has warned that the UK is "falling behind" in cancer care and questioned the UK's commitment to innovation, after an ovarian cancer drug developed by British scientists was deemed too expensive to use by NHS. - Financial TimesGreece was last night urged to be 'honest with voters' about the parlous state of the country's finances as hopes of an imminent deal to resolve the debt crisis were dashed. Prime Minister Alexis Tsipras insisted his government had 'submitted a realistic plan for Greece to exit the crisis' after weeks of wrangling with its international lenders. - The Daily MailCenter Parcs UK is expected to consider expansion in North America, after its sale for more than £2.4bn to Brookfield Property Partners, the Canadian property group that part owns Canary Wharf. The holiday village operator, which last year opened its fifth venue in Britain, in Woburn Forest, has announced plans for a new €200m village in Ireland but its new owners are likely to back a move further afield. - The TimesFashion retailer New Look has unveiled plans to more than double its number of Chinese stores after delivering a surge in annual profits. The chain, which recently agreed to a £780m takeover offer, has 30 stores in China, the world's second-largest economy, and has set itself a target of growing that figure to 70 by March next year. - ScotsmanPrices in British shops have moved into their third year of decline as a result of widespread supermarket discounting and cheaper fresh food , according to new industry figures. The British Retail Consortium (BRC) said shop prices in May were down 1.9% on last year's levels, unchanged from April's rate of decline and the 25th straight month of deflation. - The Guardian
More News
16 Apr 2024 09:30
Boehringer replaces Bayer as Germany's largest drugmaker on Jardiance gains
INGELHEIM, Germany, April 16 (Reuters) - Boehringer Ingelheim on Tuesday overtook Bayer as Germany's largest drugmaker when the unlisted company reported a currency-adjusted gain in 2023 pharmaceutical sales of 10.3% to 20.8 billion euros ($22.11 billion).
Read more16 Apr 2024 08:39
AstraZeneca's hails Imfinzi survival data on cancer form
(Alliance News) - AstraZeneca PLC on Tuesday said that its immunotherapy Imfinzi showed positive survival rate in people with advanced biliary tract cancer.
Read more12 Apr 2024 12:55
EU regulator rules out link between weight-loss drugs and suicidal thoughts
April 12 (Reuters) - The European Union drug regulator found no evidence that a class of diabetes and weight-loss drugs such as Novo Nordisk's hugely popular Wegovy, are linked to suicidal thoughts, it said on Friday, ending a nine-month probe.
Read more11 Apr 2024 18:51
AstraZeneca CEO could earn 19 million pounds as pay measure clears opposition
Policy approved with two-third of votes in favour
*Read more11 Apr 2024 17:13
FTSE 100 edges lower as financials drag
Lok'nStore surges to all-time high after buyout by Shurgard
*Read more11 Apr 2024 17:07
Banks weigh down Europe's STOXX 600 after ECB signals rate cuts
Outlook hike sends Ambu shares up
*Read more11 Apr 2024 15:56
London close: Stocks finish lower as ECB stands pat
(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.
Read more11 Apr 2024 11:50
LONDON MARKET MIDDAY: Europe takes hit on nerves ahead of ECB decision
(Alliance News) - European equities sunk lower at midday on Thursday, with sentiment hurt by hotter-than-expected inflation from the US crushing hopes of interest rate cuts.
Read more11 Apr 2024 08:56
TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023
(Alliance News) - AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performance and cash generation.
Read more11 Apr 2024 08:54
LONDON MARKET OPEN: European markets mixed ahead of ECB decision
(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.
Read more11 Apr 2024 07:49
LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance
(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.
Read more11 Apr 2024 07:20
AstraZeneca to hike 2024 dividend by 7%
(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.
Read more8 Apr 2024 08:36
TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris
(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.
Read more8 Apr 2024 07:43
LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack
(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.
Read more